Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Global Autoimmune Collaboration and Licensing Deals Analysis Report and Directory 2023
November 07, 2023 04:53 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The "Autoimmune Collaboration...
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Detailed Profiles of 56 Anti-CLDN18.2 Immunotherapy Candidates
September 22, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry...
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023 16:05 ET
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...
Oncology Drugs Global Market Opportunities and Strategies to 2032
May 25, 2023 09:33 ET
|
Research and Markets
Dublin, May 25, 2023 (GLOBE NEWSWIRE) -- The "Oncology Drugs Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Cancer Immunotherapy Global Market to 2032: Rising Cancer Incidence is Expected to Propel the Sector
April 26, 2023 09:33 ET
|
Research and Markets
Dublin, April 26, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Autoimmune Partnering 2016-2023: Deal Trends, Players and Financials
April 03, 2023 05:53 ET
|
Research and Markets
Dublin, April 03, 2023 (GLOBE NEWSWIRE) -- The "Global Autoimmune Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.Global...
BiondVax Announces Closing of $8 Million Underwritten Public Offering
December 20, 2022 12:42 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Dec. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV)(“Company”), a biotechnology company, which focuses on developing, manufacturing, and...
IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.
December 06, 2022 08:30 ET
|
BiondVax Pharmaceuticals Ltd.
LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...
Global Autoimmune Partnering Deals Report 2022: Disease Deal Trends, Key Players and Top Deal Values
December 06, 2022 07:08 ET
|
Research and Markets
Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Autoimmune Partnering 2015-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.Global...